 This causes PKM2 to transition from its low-activity dimeric form to a highly active tetrameric form.In cancer cells, the ratio between dimeric and tetrameric forms of PKM2 determines what happens to glucose carbons.If PKM2 is in the dimeric form, glucose is channeled into synthetic processes such as nucleic acid, amino acid, or phospholipid synthesis.